Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Hengyu Lu

SHP2 Inhibition Overcomes RTK-mediated Pathway Re-Activation in KRAS Mutant Tumors Treated With MEK Inhibitors

Molecular Cancer Therapeutics

Cancer Research

English

Related publications

SHP2 Inhibition Prevents Adaptive Resistance to MEK Inhibitors in Multiple Cancer Models

Cancer Discovery

English

Combined MEK and BCL-XL Inhibition Kills KRAS -Mutant Cells

Cancer Discovery

English

Shipping Out MEK Inhibitor Resistance With SHP2 Inhibitors

Cancer Discovery

English

RAF Dimer Inhibition Enhances the Antitumor Activity of MEK Inhibitors in K‐RAS Mutant Tumors

Molecular Oncology

Cancer Research

Molecular Medicine

English

Erratum: Mechanism of MEK Inhibition Determines Efficacy in Mutant KRAS- Versus BRAF-driven Cancers

Multidisciplinary

English

Combination PI3K/MEK Inhibition Promotes Tumor Apoptosis and Regression in PIK3CA Wild-Type, KRAS Mutant Colorectal Cancer

Cancer Research

English

Synthetic Lethal Interaction of Combined BCL-XL and MEK Inhibition Promotes Tumor Regressions in KRAS Mutant Cancer Models

Cancer Research

English

Allosteric Inhibitors Target KRAS in a Mutant-Specific Manner

Cancer Discovery

English

Effective Use of PI3K and MEK Inhibitors to Treat Mutant Kras G12D and PIK3CA H1047R Murine Lung Cancers

Nature Medicine

Molecular Biology

English